SHPA calls for tightened S8 opioid restrictions

The SHPA has suggested limiting pack sizes, indications and dose limits for S8 opioids In its submission to the TGA’s consultation on S8 opioid use and misuse in Australia – options for a regulatory response, the SHPA also suggests limiting the duration of a script’s validity. “SHPA is pleased to see that recent regulatory action